Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of Novartis Meningococcal ACWY conjugate vaccine in healthy subjects 11–55 years in Korea
2014-005055-11Phase 3
- Sponsor
- Novartis
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in meningococcal disease comparing Novartis Meningococcal ACWY conjugate vaccine with Placebo (2 arms). Primary endpoints: Primary immunogenicity endpoints and Safety endpoints.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2014-005055-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005055-11.